Common Hawthorn for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Hawthorn, a shrub, yields leaf-and-flower extracts sold as heart-tonic supplements, mostly studied in heart patients; benefit for others remains uncertain. In mild heart failure, small trials found better exercise tolerance, unconfirmed by the most careful independent trial; the largest did not reduce heart events. Pooled small trials point to a modest, inconsistent fall in raised upper blood-pressure readings. It appears well tolerated; Mexican hawthorn root products contained a poisonous plant. (Full Review)

Protocol

Standardized extract for heart failure
WS 1442 450 mg twice daily
1,800 mg daily outperformed 900 mg on workload in class III disease
Blood pressure regimens
250–1,200 mg daily
Diabetes trial: 1,200 mg daily for 16 weeks alongside medication
Traditional EMA regimens
Tea of 1–2 g dried leaf and flower up to 4 times daily
Maximum 6 g; or powdered herb 570–1,750 mg daily
Time to effect
Heart failure workload
16 weeks
Workload gains found in a heart failure trial
Blood pressure
2–6 months
Effects measured in trials lasting 10 weeks to 6 months
Herbalist expectation
At least 3 months
No change after 3 months suggests no response

Benefits

Contraindications
  • Known hypersensitivity to hawthorn
  • Pregnancy and breastfeeding
  • Children and adolescents (under 18 years for heart complaints, under 12 years for stress and sleep)
  • Undiagnosed cardiac symptoms (until serious heart conditions are excluded by a doctor; medical review if symptoms persist beyond 2 weeks)
  • Heart failure with ejection fraction ≤35% without cardiology supervision
  • Users of tejocote root products
Key Interactions
  • D-Camphor (fixed hawthorn berry–camphor drops, Korodin)
  • Vitamin K antagonists (warfarin, acenocoumarol)
Theoretical (inferred from mechanism)
  • Nitrates and PDE5 inhibitors (nitroglycerin; sildenafil)
  • Antiplatelet drugs and direct anticoagulants, including over-the-counter aspirin and NSAIDs (clopidogrel, apixaban; ibuprofen)
  • Antiarrhythmic drugs (such as amiodarone)
  • Cardiac glycoside–containing herbs (such as foxglove, oleander)
  • Blood pressure–lowering supplements (hibiscus, garlic)
  • Over-the-counter decongestants (pseudoephedrine, phenylephrine)
  • Alcohol

Risk & Side Effects

  • High:
  • Medium:
  • Low: General adverse events; Early heart failure worsening; Adulterated or misidentified hawthorn products; Bleeding with anti-clotting drugs
  • Speculative: Pregnancy and breastfeeding

Monitoring

Marker Target Why
Blood pressure <130/80 mmHg Expected to change
Resting heart rate 60–100 beats per minute Safety check: unexpected slowing stops use
Serum digoxin (digoxin users only) 0.5–2.0 ng/mL Safety check: unexpected change prompts review
NT-proBNP (heart failure only) No established target; track change from own baseline Safety check: a rise signals worsening heart failure
Ejection fraction (heart failure only) Not specified in the ER Baseline reference point
Body weight (heart failure only) Not specified in the ER Safety check: tracks early heart failure worsening

Cadence: Baseline before starting; blood pressure and pulse at 2 and 4 weeks, then every 3 months; in heart failure, weight and symptoms weekly for the first 2 months and natriuretic peptide at 3 months, then every 6–12 months; digoxin users keep their scheduled levels

Qualitative Assessment

  • Exercise tolerance, such as stairs or walking distance before breathlessness
  • Fatigue and breathlessness during daily activity
  • Frequency of palpitations
  • Dizziness on standing
  • Ankle swelling and day-to-day weight stability
  • Sleep quality and perceived stress